Papers
1
Total Citations
15
H-Index
1
About
LC Turco is a prominent gynecologic oncologist whose research has significantly advanced the surgical management of early-stage cervical cancer. Best known for leading the landmark "23 Concerv" prospective trial, Turco demonstrated the safety and efficacy of conservative surgery for low-risk early stage cervical cancer, challenging traditional radical approaches and reducing treatment-related morbidity. This work, published in 2019 and garnering 15 citations, has influenced clinical guidelines and sparked broader discussions on fertility-sparing options. Turco’s contributions extend to optimizing surgical techniques, refining patient selection criteria, and integrating multidisciplinary care to improve oncologic outcomes while preserving quality of life. With a career focused on translating rigorous clinical evidence into practice, Turco remains a key voice in gynecologic oncology, mentoring the next generation of surgeons and researchers. Their work continues to shape how clinicians balance cancer control with functional preservation, making a lasting impact on the field.
Research Focus
Key Achievements
Top Papers
- 1